Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer.

Background: Current guidelines recommend genetic testing for all patients with pancreatic cancer (PC).

Methods: Patients with localized PC who received neoadjuvant therapy between 2009 and 2018 were identified. Genetic consultation (including personal and family history of cancer), genetic testing, and variant data were abstracted.